Theravance Biopharma
TBPH
TBPH
92 hedge funds and large institutions have $1.65B invested in Theravance Biopharma in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 32 increasing their positions, 29 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 11
6% less funds holding
Funds holding: 98 → 92 (-6)
69% less call options, than puts
Call options by funds: $732K | Put options by funds: $2.38M
Holders
92
Holding in Top 10
5
Calls
$732K
Puts
$2.38M
Top Buyers
| 1 | +$129M | |
| 2 | +$47M | |
| 3 | +$7.29M | |
| 4 |
WIM
Woodford Investment Management
London,
United Kingdom
|
+$7.27M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.61M |
Top Sellers
| 1 | -$13M | |
| 2 | -$12.1M | |
| 3 | -$2.95M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$2.33M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.2M |